MedTrace Logo

Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey

NCT01892943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2014-05-15

No results posted yet for this study

Summary

The objective of this survey is to establish the clinical course of vision loss and recovery in patients with a genetically confirmed diagnosis of Leber Hereditary Optic Neuropathy (LHON).

Visual acuity changes over time from onset of symptoms and from visual acuity nadir will be the main endpoint analysed.

The survey will collect historically documented visual acuity data for all patients at participating sites with a genetically confirmed diagnosis of LHON. No exclusion criteria apply. Patients are not required to attend the clinic for the survey.

Data will be collected in a completely anonymous manner. Ethical approvals and data release agreements will be obtained as required by local regulations.

Conditions

  • Leber Hereditary Optic Neuropathy (LHON)

Sponsors & Collaborators

  • European Vision Institute Clinical Research Network

    collaborator NETWORK

  • Santhera Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Jose-Alain Sahel, MD · Centre de Recherche Institut de la Vision INSERMN

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Belgium
  • Denmark
  • France
  • Italy
  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01892943 on ClinicalTrials.gov